Selective inhibition of inducible nitric oxide synthase: Effects on hemodynamics and regional blood flow in healthy and septic sheep

Critical Care Medicine

Volumn 27, Issue 1, 1999, Pages 162-167

  Booke, Michael ^a   Hinder, Frank ^a   McGuire, Roy ^a   Traber, Lillian D ^a   Traber, Daniel L ^a,b,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Hyperdynamic circulation; Inducible nitric oxide synthase; Microcirculation; Nitric oxide; Oxygen transport; Pseudomonas aeruginosa; Regional blood flow; S ethylisothiourea; Sepsis; Sheep

Indexed keywords

NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; S ETHYLISOTHIOUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; HEMODYNAMIC MONITORING; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SHEEP; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; BACTEREMIA; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; ISOTHIURONIUM; MICROCIRCULATION; MICROSPHERES; NITRIC OXIDE SYNTHASE; OXYGEN; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; SHEEP; VASOCONSTRICTOR AGENTS;

EID: 0032894854     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199901000-00045     Document Type: Article

References (47)

1. 1. Barriere SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393
2. 2. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271:226-233
3. 3. Martich GD, Boujoukos AJ, Suffredini AF: Response of man to endotoxin. Immunobiology 1993; 187:403-416
4. 4. Nelson S, Steward L, Traber L, et al: Endotoxin-induced alterations in contractility of an isolated systemic artery from sheep. Abstr. Anesthesiology 1989; 71:A541
5. 5. Nelson S, Stewart RH, Traber L, et al: Endotoxin-induced alterations in contractility of isolated blood vessels from sheep. Am J Physiol 1991; 260: H1790-H1794
6. 6. Nelson SH, Dehring DJ, Ehardt JS, et al: Regional variation in content of c-GMP and associated vascular reactivity in bacteremia. Abstr. Circ Shock 1993; 39:54
7. 7. Booke M, Meyer J, Lingnau W, et al: Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horiz 1995; 3:123-138
8. 8. Moncada S, Higgs A: The L-argininenitric oxide pathway. N Engl J Med 1993; 329:2002-2012
9. 9. Klimm J, Bein T, Fröhlich D, et al: Stickstoffmonoxid (NO)-physiologische und biochemische Bedeutung. Anasthesiol Intensivmed Notfallmed Schmerzther 1992; 33:115-123
10. 10. Tolins JP, Shultz PJ, Raij L: Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Update on humoral regulation of vascular tone. Hypertension 1991; 17:909-916
11. 11. Szabó C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3:2-32
12. 12. Hata JS, Dellinger RP: Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1995; 23: 1621-1624
13. 13. Wang P, Ba ZF, Chaudry IH: Nitric oxide. To block or enhance its production during sepsis? Arch Surg 1994; 129:1137-1142
14. 14. Southan GJ, Szabó C, Thiemermann C: Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995; 114:510-516
15. 15. Thiemermann C: Inhibition of nitric oxide synthase activity in circulatory shock: Friend or foe? In: Role of nitric oxide in sepsis and ARDS. Fink MP, Payen D (Ed). Berlin Heidelberg, Springer-Verlag, 1995, pp 201-216
16. 16. Garvey EP, Oplinger JA, Tanoury GJ, et al: Potent selective inhibition of human nitric oxide synthases - Inhibition by non-amino acid isothioureas. J Biol Chem 1994; 269:2268-2276
17. 17. Booke M, Hinder F, Traber LD, et al: S-Ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 1995; 4:274-281
18. 18. Kowallik P, Schulz R, Guth BD, et al: Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991; 83:974-982
19. 19. Booke M, Armstrong C, Hinder F, et al: Effects of propofol on hemodynamics and renal blood flow in healthy and septic sheep and combined with fentanyl in septic sheep. Anesth Analg 1996; 82:738-743
20. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, in sheep. Anesth Analg 1993; 77:1215-1221
21. 21. Booke M, Hinder F, McGuire R, et al: Nitric oxide synthase inhibition versus catecholamines for the treatment of hyperdynamic sepsis. Crit Care Med 1996; 24:835-844
22. 22. Booke M, Hinder F, McGuire R, et al: Nitric oxide synthase inhibition versus catecholamine in ovine sepsis: Effects on regional blood flow. Shock 1996; 5:362-370
23. 23. Raper RF, Sibbald WJ, Hobson J, et al: Effect of PGE1 on altered distribution of regional blood flows in hyperdynamic sepsis. Chest 1991; 100:1703-1711
24. 24. Fish RE, Lang CH, Spitzer JA: Regional blood flow during continuous low-dose endotoxin infusion. Circ Shock 1986; 18:267-275
25. 25. Lang CH, Bagby GJ, Ferguson JL, et al: Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 1984; 246: R331-R337
26. 26. Booke M, Traber LD, Traber DL: Use of nitric oxide synthase inhibitors to reverse hyperdynamic circulation and MOF. In: Role of nitric oxide in sepsis and ARDS. Fink MP, Payen D (Eds). Berlin Heidelberg, Springer-Verlag, 1995, pp 217-231
27. 27. Lübbesmeyer HJ, Woodson L, Traber LD, et al: Immunoreactive atrial natriuretic factor is increased in ovine model of endotoxemia. Am J Physiol 1988; 254:R567-R571
28. 28. Redl G, Woodson L, Traber LD, et al: Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia. Circ Shock 1992; 38:34-41
29. 29. Hinder F, Booke M, Traber LD, et al: Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically elevated atrial natriuretic peptide. Crit Care Med 1996; 24: 131-136
30. 30. Mitaka C, Nagura T, Sakanishi N, et al: Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study. Crit Care Med 1990; 18:1201-1203
31. 31. Hinder F, Booke M, McGuire R, et al: Blockage of the receptor for atrial natriuretic peptide during ovine sepsis increases pulmonary transvascular fluid flux without evidence of high-protein edema. Abstr. Anesthesiology 1995; 81:A335
32. 3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 1983; 80: 4518-4521
33. 33. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
34. 34. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81
35. 35. Shi Y, Li HQ, Shen CK, et al: Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 1993; 123: 435-438
36. 36. Guarner C, Soriano G, Tomas A, et al: Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18:1139-1143
37. 37. Wong HR, Carcillo JA, Burckart G, et al: Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 1995; 23:835-842
38. 38. Gomez Jimenez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23: 253-258
39. 39. Tresham JJ, Dusting GJ, Coghlan JP, et al: Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin Exp Pharmacol Physiol 1991; 18:327-330
40. 40. Meyer J, Hinder F, Stothert J, et al: Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 1994; 76:2785-2793
41. 41. Meyer J, Lentz CW, Stothert JC, et al: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 1994; 22:306-312
42. 42. Booke M, Traber LD, Traber DL: Vasodilators in sepsis. In: Shock, Sepsis, and Organ Failure - Nitric Oxide. Schlag G, Redl H (Eds). Heidelberg, Springer-Verlag, 1994, pp 243-264
43. 43. Förstermann U, Schmidt HH, Pollock JS, et al: Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42:1849-1857
44. 44. Schmidt HHHW, Murad F: Purification and characterization of a human NO synthase. Biochem Biophys Res Commun 1991; 181:1372-1377
45. 45. Janssens SP, Shimouchi A, Quertermous T, et al: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267:14519-14522
46. 46. Sherman PA, Laubach VE, Reep BR, et al: Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 1993; 32:11600-11605
47. 47. Nelson SH, Ehardt JS, Lingnau W, et al: Differential effects of prolonged septicemia on isolated pulmonary arteries and veins from sheep. Shock 1996; 5:440-445